|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Principia Biopharma Inc. (PRNB)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-09-18 Purchase |
2018-09-20 7:02 pm |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
270,000 | $17 | $4,590,000 | 2,038,208 (Direct Indirect) |
View |
| 2018-09-18 Purchase |
2018-09-20 6:59 pm |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
250,000 | $17 | $4,250,000 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Purchase |
2018-09-20 6:58 pm |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
270,000 | $17 | $4,590,000 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Purchase |
2018-09-20 6:53 pm |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
270,000 | $17 | $4,590,000 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Purchase |
2018-09-20 6:50 pm |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
270,000 | $17 | $4,590,000 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Purchase |
2018-09-20 5:18 pm |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
270,000 | $17 | $4,590,000 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Purchase |
2018-09-20 4:14 pm |
Principia Biopharma Inc. | PRNB | AKKARAJU SRINIVAS Director |
175,000 | $17 | $2,975,000 | 383,480 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-04-16 Option Award |
2019-04-18 4:23 pm |
N/A 2029-04-15 |
Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director |
20,475 | $27.81 | 20,475 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-08 5:42 pm |
N/A 2029-02-28 |
Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer |
60,000 | $35.42 | 60,000 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-08 5:40 pm |
N/A 2029-02-28 |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
60,000 | $35.42 | 60,000 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-08 5:38 pm |
N/A 2029-02-28 |
Principia Biopharma Inc. | PRNB | Goldstein David Chief Scientific Officer |
60,000 | $35.42 | 60,000 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-08 5:35 pm |
N/A 2029-02-28 |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
60,000 | $35.42 | 60,000 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-08 5:33 pm |
N/A 2029-02-28 |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO |
60,000 | $35.42 | 60,000 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-08 5:31 pm |
N/A 2029-02-28 |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
155,000 | $35.42 | 155,000 (Direct) |
View |
| 2019-02-19 Option Award |
2019-02-21 6:07 pm |
N/A 2029-02-18 |
Principia Biopharma Inc. | PRNB | Smither John W Director |
20,475 | $30.3 | 20,475 (Direct) |
View |
| 2018-09-13 Option Award |
2019-01-15 4:57 pm |
N/A 2028-09-12 |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
20,475 | $17 | 20,475 (Indirect) |
View |
| 2018-09-13 Option Award |
2019-01-10 9:53 pm |
N/A 2028-09-12 |
Principia Biopharma Inc. | PRNB | Shuster Lewis Director |
20,475 | $17 | 20,475 (Direct) |
View |
| 2018-09-13 Option Award |
2019-01-10 9:48 pm |
N/A 2028-09-12 |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
20,475 | $17 | 20,475 (Direct) |
View |
| 2018-09-13 Option Award |
2019-01-10 9:47 pm |
N/A 2028-09-12 |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
20,475 | $17 | 20,475 (Direct) |
View |
| 2018-09-13 Option Award |
2019-01-10 9:43 pm |
N/A 2028-09-12 |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
20,475 | $17 | 20,475 (Direct) |
View |
| 2018-09-13 Option Award |
2019-01-10 9:40 pm |
N/A 2028-09-12 |
Principia Biopharma Inc. | PRNB | AKKARAJU SRINIVAS Director |
20,475 | $17 | 20,475 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
625,482 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
521,235 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
453,954 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
167,537 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
625,482 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
521,235 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
453,954 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 7:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
167,537 | $0 | 2,038,208 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
1,070,771 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
312,741 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
260,617 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
544,047 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
167,537 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
1,070,771 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
312,741 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
260,617 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
544,047 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:59 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
167,537 | $0 | 2,605,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
1,070,771 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
312,741 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
260,617 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
544,047 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
167,537 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
1,070,771 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
312,741 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
260,617 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
544,047 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:58 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director, 10% Owner |
167,537 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
1,070,771 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
312,741 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
260,617 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
544,047 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
167,537 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
1,070,771 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
312,741 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
260,617 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
544,047 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:53 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
167,537 | $0 | 2,188,176 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
1,070,771 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
312,741 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
260,617 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
544,047 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
167,537 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
1,070,771 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
312,741 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
260,617 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
544,047 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:50 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director, 10% Owner |
167,537 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:47 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Gourlay Steve Chief Medical Officer |
7,269 | $0 | 107,857 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:47 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Gourlay Steve Chief Medical Officer |
7,269 | $0 | 107,857 (Direct) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
988 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
240 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
988 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
240 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
988 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
240 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
988 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
988 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
988 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
240 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
240 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 6:45 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin CEO |
240 | $0 | 79,179 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
1,070,771 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
312,741 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
260,617 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
544,047 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
167,537 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
9,726,783 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
2,840,909 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
2,367,424 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
4,942,070 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 5:18 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner |
1,521,895 | $0 | 2,625,713 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 4:14 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | AKKARAJU SRINIVAS Director |
208,480 | $0 | 383,480 (Indirect) |
View |
| 2018-09-18 Conversion |
2018-09-20 4:14 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | AKKARAJU SRINIVAS Director |
208,480 | $0 | 383,480 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 22 Apr 2019 01:46:25 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |